Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206370
Company: TARO
Company: TARO
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CLOCORTOLONE PIVALATE | CLOCORTOLONE PIVALATE | 0.1% | CREAM;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/21/2020 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/206370Orig1s000ltr.pdf |
CLOCORTOLONE PIVALATE
CREAM;TOPICAL; 0.1%
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| CLOCORTOLONE PIVALATE | CLOCORTOLONE PIVALATE | 0.1% | CREAM;TOPICAL | Prescription | No | AB | 206370 | TARO |
| CLODERM | CLOCORTOLONE PIVALATE | 0.1% | CREAM;TOPICAL | Prescription | Yes | AB | 017765 | LEGACY PHARMA |